Ozen Seza, Anton Jordi, Arisoy Nil, Bakkaloglu Aysin, Besbas Nesrin, Brogan Paul, García-Consuegra Julia, Dolezalova Pavla, Dressler Frank, Duzova Ali, Ferriani Virgínia Paes Leme, Hilário Maria Odete Esteves, Ibáñez-Rubio Mercedes, Kasapcopur Ozgur, Kuis Wietse, Lehman Thomas J A, Nemcova Dana, Nielsen Susan, Oliveira Sheila Knupp, Schikler Kenneth, Sztajnbok Flavio, Terreri Maria Teresa, Zulian Francesco, Woo Patricia
Department of Pediatrics, Hacettepe University, Ankara, Turkey.
J Pediatr. 2004 Oct;145(4):517-22. doi: 10.1016/j.jpeds.2004.06.046.
To characterize pediatric patients who had been diagnosed with polyarteritis nodosa (PAN) through necrotizing vasculitis of the small and mid-size arteries or those with characteristic findings on angiograms data were collected.
Pediatricians were asked to classify their patients into one of the four suggested groups for juvenile PAN. Twenty-one pediatric centers worldwide participated with 110 patients.
The girl:boy ratio was 56:54, with a mean age of 9.05 +/- 3.57 years. The cases were classified as: 33 (30%) cutaneous PAN; 5 (4.6%) classic PAN associated with hepatitis B surface antigen (HBs Ag); 9 (8.1%) microscopic polyarteritis of adults associated with antineutrophil cytoplasmic antibodies (ANCA); and 63 (57.2%) systemic PAN. Cutaneous PAN was disease confined to the skin and musculoskeletal system. All patients with HBs Ag-associated classic PAN were diagnosed with renal angiograms. Antiviral treatment was administered in most cases. Microscopic PAN patients had pulmonary-renal disease, in combination or separately. ANCA was present in 87%, and 2 patients progressed to end-stage renal failure. Patients classified with systemic PAN had multiple system involvement, almost all had constitutional symptoms, and all had elevated acute phase reactants. Corticosteroids and cyclophosphamide were the first choices of immunosuppressive treatment. The overall mortality was 1.1%.
There were remarkable differences among pediatric patients with PAN, with different clinical manifestations and overall better survival and lower relapse rates when compared with adults.
通过收集中小动脉坏死性血管炎或血管造影特征性表现诊断为结节性多动脉炎(PAN)的儿科患者数据,对其进行特征描述。
要求儿科医生将其患者分类为青少年PAN的四个建议组之一。全球21个儿科中心参与,共110例患者。
男女比例为56:54,平均年龄9.05±3.57岁。病例分类如下:33例(30%)皮肤型PAN;5例(4.6%)与乙肝表面抗原(HBs Ag)相关的典型PAN;9例(8.1%)与抗中性粒细胞胞浆抗体(ANCA)相关的成人显微镜下多动脉炎;63例(57.2%)系统性PAN。皮肤型PAN局限于皮肤和肌肉骨骼系统。所有与HBs Ag相关的典型PAN患者均通过肾血管造影确诊。大多数病例给予抗病毒治疗。显微镜下多动脉炎患者有肺肾疾病,可合并或单独出现。87%的患者存在ANCA,2例进展为终末期肾衰竭。分类为系统性PAN的患者有多系统受累,几乎所有患者都有全身症状,且所有患者急性期反应物均升高。糖皮质激素和环磷酰胺是免疫抑制治疗的首选。总死亡率为1.1%。
儿科PAN患者存在显著差异,与成人相比有不同的临床表现,总体生存率更高,复发率更低。